CLASP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.03000000004372E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.464450E-03 |
Normal-vs-Stage2 |
6.219200E-04 |
Normal-vs-Stage3 |
1.59738999999659E-05 |
Normal-vs-Stage4 |
1.48050000003952E-06 |
Stage1-vs-Stage2 |
1.410570E-01 |
Stage1-vs-Stage3 |
5.650100E-02 |
Stage1-vs-Stage4 |
1.038090E-02 |
Stage2-vs-Stage3 |
9.178400E-01 |
Stage2-vs-Stage4 |
5.520200E-01 |
Stage3-vs-Stage4 |
3.702000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.89291000000091E-05 |
Normal-vs-AfricanAmerican |
3.54790000000049E-05 |
Normal-vs-Asian |
7.779000E-01 |
Caucasian-vs-AfricanAmerican |
6.316200E-02 |
Caucasian-vs-Asian |
5.988000E-02 |
AfricanAmerican-vs-Asian |
1.954010E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.03660000000594E-06 |
Normal-vs-Female |
3.760400E-04 |
Male-vs-Female |
2.307200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.444100E-02 |
Normal-vs-Age(41-60Yrs) |
1.750980E-04 |
Normal-vs-Age(61-80Yrs) |
1.79055999999234E-05 |
Normal-vs-Age(81-100Yrs) |
1.035050E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.642000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.993800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.508000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.212000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.025230E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.359400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.657000E-01 |
Normal-vs-Grade 2 |
2.718100E-03 |
Normal-vs-Grade 3 |
1.2571999999933E-06 |
Normal-vs-Grade 4 |
2.60139999985753E-07 |
Grade 1-vs-Grade 2 |
9.218000E-02 |
Grade 1-vs-Grade 3 |
7.258400E-03 |
Grade 1-vs-Grade 4 |
5.552200E-04 |
Grade 2-vs-Grade 3 |
3.321700E-02 |
Grade 2-vs-Grade 4 |
7.007800E-04 |
Grade 3-vs-Grade 4 |
8.042000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.818700E-03 |
Normal-vs-ccB subtype |
5.76219999999239E-05 |
ccA subtype-vs-ccB subtype |
2.316100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.47080000000244E-05 |
Normal-vs-N1 |
4.345900E-02 |
N0-vs-N1 |
8.612400E-01 |
|
|